Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Rheumatology

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/kes316PMID 23204549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tale of TL1A in inflammation

  2011cited by this paper
• Insights into TL1A and IBD pathogenesis.

  2011cited by this paper
• Upregulation and nuclear localization of TNF‐like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions

  2011cited by this paper
• Constitutive TL1A (TNFSF15) Expression on Lymphoid or Myeloid Cells Leads to Mild Intestinal Inflammation and Fibrosis

  2011cited by this paper
• 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

  2011cited by this paper
• Immunology: TL1A in the inflammatory network in autoimmune diseases

  2010cited by this paper
• Role of TL1A in the Pathogenesis of Rheumatoid Arthritis1

  2009cited by this paper
• The role of TNF superfamily members in T-cell function and diseases

  2009cited by this paper
• The Death Receptor 3–TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis

  2008cited by this paper
• Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.

  2008cited by this paper
• Ankylosing spondylitis.

  2007cited by this paper
• Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases

  2005cited by this paper
• Gut inflammation and spondyloarthropathies

  2002cited by this paper
• TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

  2002cited by this paper
• Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

  1995cited by this paper
• Ankylosing Spondylitis

  1955cited by this paper
• Extended Report

  year unknowncited by this paper

• The Therapeutic Potential of Targeting TL1A in a Spectrum of Inflammatory Disorders

  2026cites this paper
• TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential

  2025cites this paper
• The TL1A inhibitors in IBD: what’s in the pot?

  2025cites this paper
• Serum levels of tumor necrosis factor-like cytokine 1A and its receptors, death receptor 3 and decoy receptor 3, in patients with spondyloarthropathies: preliminary results from a cross-sectional study

  2025influential citation
• Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?

  2024cites this paper
• TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis.

  2024cites this paper
• Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors

  2022cites this paper
• Constructing Causal Cytokine Networks for Autoimmune and Inflammatory Diseases Target Identification

  2022cites this paper
• TL1A as a therapeutic target in inflammatory bowel disease

  2022cites this paper
• Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review

  2022cites this paper
• TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling

  2020influential citation
• Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF

  2020cites this paper
• A TRAIL-TL1A Paracrine Network Involving Adipocytes, Macrophages, and Lymphocytes Induces Adipose Tissue Dysfunction Downstream of E2F1 in Human Obesity

  2020cites this paper
• The haplotypes of various TNF related genes associated with scleritis in Chinese Han

  2020cites this paper
• Tumour necrosis factor like cytokine 1A levels and lesion complexity in non-smoking patients with coronary artery disease

  2019cites this paper
• TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity

  2019cites this paper
• Association between TL1A gene polymorphisms and systemic lupus erythematosus in a Chinese Han population

  2019cites this paper
• Increased circulating levels of tumor necrosis factor-like cytokine 1A and decoy receptor 3 correlate with SYNTAX score in patients undergoing coronary surgery

  2018cites this paper
• Gene polymorphisms and serum levels of TL1A in patients with rheumatoid arthritis

  2018cites this paper
• A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell

  2017cites this paper
• Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese

  2017cites this paper
• Multifaceted death receptor 3 signaling—promoting survival and triggering death

  2017cites this paper
• Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis

  2017cites this paper
• Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis

  2016cites this paper
• The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

  2016cites this paper
• Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling

  2016cites this paper
• Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.

  2016cites this paper
• Biologics beyond TNF-α inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders

  2016cites this paper
• Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice

  2015cites this paper
• The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.

  2015cites this paper
• Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients

  2015cites this paper
• Association of Genetic Variations in TNFSF15 With Acute Anterior Uveitis in Chinese Han.

  2015cites this paper
• The TNF‐family cytokine TL1A: from lymphocyte costimulator to disease co‐conspirator

  2015cites this paper
• Genetic analysis of TNFST15 variants in ankylosing spondylitis.

  2015cites this paper
• Tumor Necrosis Factor–like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation

  2015cites this paper
• TL1A Induces TCR Independent IL-6 and TNF-α Production and Growth of PLZF+ Leukocytes

  2014cites this paper
• Seminars in Arthritis and Rheumatism

  2013cites this paper
• Death receptor 3 : a regulator of bone turnover and new target for therapy for osteoporosis?

  2013influential citation
• The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation

  2013cites this paper
• Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis.

  2013cites this paper